Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ia/Ib Trial of Anti-PSMA Designer T Cells in Prostate Cancer After Non-Myeloablative Conditioning

NCT01929239 is registered in ClinicalTrials.gov with Roger Williams Medical Center as lead sponsor.

NCT NCT01929239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01929239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ia/Ib Trial of Anti-PSMA Designer T Cells in Prostate Cancer After Non-Myeloablative Conditioning
Lead sponsor
Roger Williams Medical Center
Phase
Phase 1/2
Overall status
Suspended
Start date
March 31, 2006
Completion date
December 31, 2018
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

monitor adverse events